EGIS PHARMACEUTICALS PLC Patent applications |
Patent application number | Title | Published |
20140161889 | TRANSDERMAL FORMULATION CONTAINING COX INHIBITORS - Disclosed are gel compositions suitable for the topical administration of an active compound having poor solubility and skin penetration, for example, of a COX-2 inhibitor compounds, processes of preparation thereof and methods of use thereof for the treatment of indications treatable by the active compound. | 06-12-2014 |
20140039028 | TRANSDERMAL FORMULATION CONTAINING COX INHIBITORS - Disclosed are gel compositions suitable for the topical administration of an active compound having poor solubility and skin penetration, for example, of a COX-2 inhibitor compounds, processes of preparation thereof and methods of use thereof for the treatment of indications treatable by the active compound. | 02-06-2014 |
20140037738 | TRANSDERMAL FORMULATION CONTAINING COX INHIBITORS - Disclosed are gel compositions suitable for the topical administration of an active compound having poor solubility and skin penetration, for example, of a COX-2 inhibitor compounds, processes of preparation thereof and methods of use thereof for the treatment of indications treatable by the active compound. | 02-06-2014 |
20130259904 | PRASUGREL CONTAINING QUICKLY RELEASED STABLE ORAL PHARMACEUTICAL COMPOSITIONS - Prasugrel containing quickly released stable oral pharmaceutical compositions containing micronized prasugrel base, and starch or a starch derivative, and processes for the preparation thereof, and the use thereof for treating atherothrombotic events of patients suffering from acute coronary syndrome in which patients were subjected to percutaneous coronary intervention. | 10-03-2013 |